fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Clinical trial reveals new treatment option for COVID-19

Written by | 16 Mar 2022

A clinical trial conducted by researchers from RCSI University of Medicine and Health Sciences and Beaumont Hospital Dublin has indicated an effective treatment for critically ill COVID-19 patients…. read more.

Mass media and building trust

Written by | 13 Mar 2022

Open discussion of the scientific evidence and the uncertainties could have generated less political polarisation, less wasted expenditure but built more trust, according to Allyson Pollock, Clinical Professor… read more.

Model of the human nose reveals first steps of SARS-CoV-2 and RSV infection

Written by | 12 Mar 2022

Preclinical models that recapitulate aspects of human airway disease are essential for the advancement of novel therapeutics and vaccines. In the current study published in the journal mBIO, researchers… read more.

Natural immunity and protecting children

Written by | 12 Mar 2022

Covid is far less serious for children, long-covid is not a big issue and many also have natural immunity – all of which raises questions over whether children… read more.

Mental health service use for children and young people reduced over a fourth in the beginning of COVID-19 pandemic

Written by | 11 Mar 2022

A recently published extensive systematic review showed a 28% reduction in mental health service use in the early phase of the COVID-19 pandemic among children and young people…. read more.

Covid passports – the questions to ask

Written by | 11 Mar 2022

There are several theoretical reasons for implementing vaccine passports but now that none of these apply any longer in the UK it is difficult to see a rationale… read more.

Covid vaccination – the knowns and unknowns

Written by | 10 Mar 2022

Many factors influence decisions about vaccine use including many ‘unknowns’ and this raises questions about the wisdom of targeting young people and recommending boosters for everyone, explains Allyson… read more.

Mass testing – in theory and in practice

Written by | 9 Mar 2022

There was no evidence that mass testing stopped or prevented the transmission of covid-19, according to Professor Allyson Pollock, Clinical Professor of Public Health, Newcastle University. “Mass testing… read more.

Ivermectin associated with lower mortality than remdesivir

Written by | 8 Mar 2022

An analysis of the records more than 41,000 patients who had covid-19 and were treated with either ivermectin or remdesivir showed that ivermectin was associated with significantly lower… read more.

Evidence-based public health: Covid control measures

Written by | 8 Mar 2022

As the coronavirus pandemic appears to be running out of steam it is important to review the lessons learned and move forward to ‘living with the virus’. IMI… read more.

Revocation of vaccine mandates – effective 15th March

Written by | 1 Mar 2022

90% of respondents supported revocation of the vaccine mandate, in a public consultation exercise carried out in February 2022. The UK Government has today (March 1st) published its… read more.

Years of life lost during the pandemic significantly higher in deprived areas, study finds

Written by | 21 Feb 2022

Communities in the North West of England experienced more than three times the excess years of life lost in the South West. The impact of the COVID-19 pandemic… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.